Drug Interaction Study Between Erdosteine and Bepotastine Besilate in Healthy Adult Volunteers

Inclusion Criteria: * Healthy male subjects aged 20 - 45 years * A body mass index in the range 18.5 - 25 kg/m2 * Willingness to participate during the entire study period * Written informed consent after being fully informed about the study procedures Exclusion Criteria: * Any past medical history of hepatic, renal, gastrointestinal, respiratory, endocrine, psychiatric, neurologic, haemato-oncologic or cardiovascular disease * History of clinically significant drug hypersensitivity * Use of medication within 7 days before the first dose * Heavy drinker/smoker * Whole blood donation during 60 days before the study * Judged not eligible for study participation by investigator